Add BrightSurf on Google Email

University of North Carolina Health Care


Neurological underpinnings of schizophrenia just as complex as the disorder itself

A new study maps specific schizophrenia symptoms to distinct brain circuits, revealing novel connections between cognitive, emotional, and intellectual symptoms. The findings have important implications for diagnosis and treatment, suggesting that brain scans could help identify individual patients and track progress during therapy.

SourceUniversity of North Carolina Health Care·JournalMolecular Neuropsychiatry·DateNov 24, 2015

Children with severe obesity may be at higher risk for heart disease and diabetes

A new study found a direct correlation between severe childhood obesity and increased risk factors for heart disease and diabetes in boys. The study's lead investigator noted that understanding elevated risk in children with more severe obesity can help target testing and interventions to prevent future disease.

SourceUniversity of North Carolina Health Care·JournalNew England Journal of Medicine·DateSep 30, 2015

New study questions clinical trial data for kidney cancer drugs

A new study published in the Journal of Oncology Practice found that patients participating in stage III renal cell cancer drug trials are often younger and healthier than those who ultimately receive the drugs. The study highlights concerns about the direct applicability of trial data, particularly for patients with more advanced canc...

SourceUniversity of North Carolina Health Care·JournalJournal of Oncology Practice·DateSep 23, 2015

UNC doctors analyze treatment options for gallbladder disease

A new review article analyzes five interventional approaches to gallbladder disease, including laparoscopic cholecystectomy, NOTES, and endoscopic transmural drainage. The authors highlight the potential benefits of these minimally invasive procedures, which offer alternatives to traditional surgery and can improve patient outcomes.

SourceUniversity of North Carolina Health Care·JournalNew England Journal of Medicine·DateJul 22, 2015

Researchers find new approach to treat drug-resistant HER2-positive breast cancer

Researchers have identified various ways that HER2-positive breast cancer tumors resist therapy and discovered a potential combination therapy to overcome multiple mechanisms of resistance. A novel combination of lapatinib and a BET bromodomain inhibitor was found to block the growth of cancer cells, making the activity of lapatinib du...